In addition, quercetin inhibits the infection ability of Epstein-Barr virus (EBV) and also attenuates the resistance to drug therapy, by activating Stat3 receptor and reducing the levels of interleukin-6 (IL-6) and reactive oxygen species (ROS), key factors in B-cell survival [16]. This evidence concerns the gene IL6 and infection.